Person

Quintin J. Lai

Formerly VP Strat & Investor Relations, West Pharmaceutical Services

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$15.8M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 11, 2023WSTSale10,725$394.62$4.2M
Aug 11, 2023WSTSale8,635$395.54$3.4M
Aug 11, 2023WSTSale1,741$396.12$690K
Mar 14, 2022WSTSale200$374.92$75K
Mar 14, 2022WSTSale2,940$374.45$1.1M
Mar 14, 2022WSTSale600$371.89$223K
Mar 14, 2022WSTSale900$372.92$336K
Mar 14, 2022WSTSale446$370.94$165K
Mar 14, 2022WSTSale1,254$369.86$464K
Mar 14, 2022WSTSale405$367.94$149K
Mar 14, 2022WSTSale1,271$367.12$467K
Sep 10, 2021WSTSale3,100$460.80$1.4M
Sep 10, 2021WSTSale5,072$460.18$2.3M
Sep 10, 2021WSTSale1,500$462.63$694K

SEC reporting-owner ID (CIK) 1744326 · all filings on EDGAR

Quintin J. Lai | USBoard